Featured
What You Need to Know About the Hydrus Microstent
The trimodal design maximizes flow through an inlet structure.
By Fady Sedarous, MD, Evan Michaelov, MD, Georges M. Durr, MD, et al.
Aqueous Humor Outflow Imaging
See where the aqueous is flowing.
By Goichi Akiyama, MD, PhD, Alex S. Huang, MD, PhD
In Search of the Best Glaucoma Drop
How big should the drop be, and how much drug is needed?
By Sean Ianchulev, MD, MPH
Best Approaches to Early Glaucoma Diagnosis
Informed interpretation of structural and functional testing is critical to detection.
By Leonard K. Seibold, MD, JEFFREY SOOHOO, MD, MBA, MALIK KAHOOK, M.D.
Glaucoma Mantras
Communicating with patients in ways that speak to them.
WEB EXCLUSIVE: Apps for Glaucoma Management
Options abound for education and calculations.
By Nathan M. Radcliffe, MD
Departments
From the Editor: The Glaucoma Toolbox
An increasing number of tools are available.
By Nathan M. Radcliffe, MD
Coding: Billing Multiple Procedures Together
Identify only the codes you need.
By Kevin J. Corcoran, COE, CPC, CPMA, FNAO
Patients Are Asking: “Why Is Your Office So Busy?”
The latest data on physician supply and demand.
By Jonathan S. Myers, M.D., Douglas
Dogma vs Data: Using “Champagne Bubbles” to Titrate SLT Power
Data are needed to support the most appropriate power setting.
By JEFFREY SOOHOO, MD, MBA, Leonard K. Seibold, MD, MALIK KAHOOK, M.D.
Product Spotlight: Comprehensive Analysis to Track Glaucoma Progression
The Zeiss Cirrus HD-OCT provides an integrated view of data.
By Karen Appold, contributing writer
Web Exclusives
FDA Approves Rocklatan IOP-Lowering Combination
Approval was based on data from the phase 3 MERCURY 1 and MERCURY 2 trials.
By Jerry Helzner, contributing editor
Nitric Oxide Demonstrates Ability to Improve Outflow
By Jerry Helzner, contributing editor
Sustained-Release Bimatoprost Effective in Phase 3
By Jerry Helzner, contributing editor
Eyenovia Microdose Delivers Glaucoma Drugs on Target
By Jerry Helzner, contributing editor
Expanded Visual Field Detects Macular Damage
By Jerry Helzner, contributing editor
Study Shows Meditation Helps Lower IOP
By Jerry Helzner, contributing editor
AI Effective in Diagnosing Glaucoma
By Jerry Helzner, contributing editor
IOP Sensor for Continual Monitoring
By Jerry Helzner, contributing editor
iStent Inject Excels in 3-Year Study
By Jerry Helzner, contributing editor
iStar Miniject MIGS Effective in Trial
By Jerry Helzner, contributing editor
Medication Reminders Seen as Helpful
By Jerry Helzner, contributing editor
Chemical in Marijuana Raises IOP
By Jerry Helzner, contributing editor
Rhopressa Effective in Japanese Americans
By Jerry Helzner, contributing editor